In this study, we sought to investigate the effects of dose escalation using focal boost (FB) to intraprostatic lesions (IPLs) and 68Ga-PSMA-PET/CT for staging and RT planning in patients with GS 10 PCa undergoing definitive RT and ADT using modern RT techniques. This evidence concerns the gene FOLH1 and posterior cortical atrophy.